Everything You Need to Know About the FDA Peptide Ban The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Industry Update: Interim 503A and 503B Bulks Lists New Revisions Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Compounded "semaglutide" is not FDA approved semaglutide.com